Publication Name	World Journal of Clinical Cases
Manuscript ID	85769
Country	China

Received	2023-05-24 01:15
Peer-Review Started	2023-05-24 01:15
To Make the First Decision
Return for Revision	2023-06-12 02:38
Revised	2023-06-15 05:53
Second Decision	2023-07-18 02:43
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2023-07-18 04:01
Articles in Press	2023-07-18 04:01
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2023-07-31 07:25
Publish the Manuscript Online	2023-08-16 06:59

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Obstetrics & Gynecology
Manuscript Type	Retrospective Study
Article Title	Efficacy and prognosis of adjuvant treatment of endometrial cancer with medroxyprogesterone acetate COX regression analysis
Manuscript Source	Unsolicited Manuscript
All Author List	Ding-Ran Wang
ORCID	Author(s) ORCID Number Ding-Ran Wang http://orcid.org/0000-0001-8500-7575
Funding Agency and Grant Number
Corresponding Author	Ding-Ran Wang, PhD, Attending Doctor, Department of Obstetrics and Gynaecology, Peking University Third Hospital, No. 49 Huayuan North Road, Haidian District, Beijing 100191, China. ydausidb@163.com
Key Words	Endometrial cancer; Independent risk factors; Postoperative adjuvant therapy; Clinical analysis; Prognostic analysis
Core Tip	Adjuvant treatment with medroxyprogesterone acetate may have potential long-term prognostic benefits for patients with early-stage high-risk endometrial cancer. Age, pathological type, molecular typing, and myometrial infiltration were identified as relevant factors affecting patient prognosis.
Publish Date	2023-08-16 06:59
Citation	Wang DR. Efficacy and prognosis of adjuvant treatment of endometrial cancer with medroxyprogesterone acetate COX regression analysis. World J Clin Cases 2023; 11(23): 5447-5454
URL	https://www.wjgnet.com/2307-8960/full/v11/i23/5447.htm
DOI	https://dx.doi.org/10.12998/wjcc.v11.i23.5447

Full Article (PDF)	WJCC-11-5447-with-cover.pdf
Full Article (Word)	WJCC-11-5447.docx
Manuscript File	85769_Auto_Edited-JLW.docx
Answering Reviewers	85769-Answering reviewers.pdf
Audio Core Tip	85769-Audio core tip.m4a
Biostatistics Review Certificate	85769-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form	85769-Conflict-of-interest statement.pdf
Copyright License Agreement	85769-Copyright license agreement.pdf
Signed Informed Consent Form(s) or Document(s)	85769-Informed consent statement.pdf
Institutional Review Board Approval Form or Document	85769-Institutional review board statement.pdf
Non-Native Speakers of English Editing Certificate	85769-Language certificate.pdf
Peer-review Report	85769-Peer-review(s).pdf
Scientific Misconduct Check	85769-Bing-Chen YL-2.png
Scientific Editor Work List	85769-Scientific editor work list.pdf